American Society for Clinical Pharmacology and Therapeutics

Clinical Pharmacology & Therapeutics (1999) 65, 118–118; doi:

Dose ranging trial of the effect of MK-966 in primary dysmenorrhea.

Stephen Daniels DO1, Briggs W. Morrison MD2, Norma Cantu RN1, Michael Sandler2, Lisa McCrary2, Paul Kotey PhD2 and Beth Seidenberg MD2

  1. 1SCIREX, Austin, TX.
  2. 2Merck & Co, Inc., Rahway, NJ.

Extra navigation

.

naturejobs

More science jobs
Post a job for free

natureproducts


ADVERTISEMENT